1. European Medicines Agency. Pradaxa [dabigatran etexilate], product information. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000829/WC500041059.pdf (28 September 2015).
2. European Medicines Agency. Xarelto [rivaroxaban], product information. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000944/WC500057108.pdf (17 July 2015).
3. European Medicines Agency. Eliquis [apixaban], product information. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002148/WC500107728.pdf (29 October 2015).
4. European Medicines Agency. Lixiana [edoxaban], product information. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002629/WC500189045.pdf (03 July 2015).
5. Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemo